Moore Capital Management’s Ibere Pharmaceuticals Warrants IBER.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.WS
Moore Capital Management's IBER.WS Position: Q1 2023 in Review
Moore Capital Management sold out of Ibere Pharmaceuticals Warrants (IBER.WS) in Q1 2023, closing a stake of 150,000 shares — an estimated $2.67K sold.
Moore Capital Management first reported a position in IBER.WS in Q2 2021 and held it in 7 quarters. The position peaked at $114K in Q2 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.
- Moore Capital Management reported no remaining Ibere Pharmaceuticals Warrants position as of Q1 2023 after selling out during the quarter.
- Moore Capital Management sold 150,000 Ibere Pharmaceuticals Warrants shares in Q1 2023, an estimated $2.67K.
- Moore Capital Management first reported a position in Ibere Pharmaceuticals Warrants in Q2 2021 and held it in 7 quarters.
- Moore Capital Management's Ibere Pharmaceuticals Warrants position peaked at $114K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Warrants as of Q1 2023.
Based on Moore Capital Management's 13F filing for Q1 2023, filed 15 May 2023.